Follow project updates, notices and operational progress in a single yearly archive.
CNIPA has published Suzhou Hengchang Biotechnology's patent application for a chromium-free composite catalyst (No. CN122682613A), supporting cleaner production of N-methylaniline.
In June 2026, Suzhou Hengchang Biotechnology Co., Ltd. was officially recognized as a 2026 Suzhou basic-level smart factory for its intelligent upgrading, data integration, and green transformation.
In March 2026, HC Technology was granted a utility model patent (No. CN224047052U) for an N-methylaniline wastewater treatment device whose dual-stage series adsorption structure enables online resin transfer and replacement, plus regeneration without shutdown.
Suzhou Hengchang Biotechnology Co., Ltd. has officially launched a comprehensive website renovation, covering page design, product information, factory photographs, and overall user experience improvements.
On March 22, 2026, the Party Secretary of Suzhou reviewed key technical upgrading projects in the Suzhou Economic Development Zone, making the company his first stop. He toured the central control room, observed production lines, and learned about financing and market sales, encouraging key technology breakthroughs, process optimization, and market expansion.
In October 2025, Suzhou Hengchang Biotechnology Co., Ltd. signed one of Suzhou's first overseas IP rights-protection insurance policies. The coverage helps cut the cost of defending its IP rights overseas and supports the company's international business.
Since late 2024, the company has received a total of 15 million CNY in working capital support in tranches coordinated by the Suzhou Economic Development Zone, funding operations during the advancement of its pharmaceutical excipient and 3,000-ton annual capacity N-methylaniline upgrading projects.
In December 2024, the company's 3,000-ton annual capacity N-methylaniline technical upgrading project passed the safety facility design review by the Suzhou Municipal Emergency Management Bureau, following its safety conditions review approval in August 2024. Both safety review procedures are complete, laying a compliance foundation for project implementation.
CNIPA has published Suzhou Hengchang Biotechnology's patent application for a chromium-free composite catalyst (No. CN122682613A), supporting cleaner production of N-methylaniline.
In June 2026, Suzhou Hengchang Biotechnology Co., Ltd. was officially recognized as a 2026 Suzhou basic-level smart factory for its intelligent upgrading, data integration, and green transformation.
In March 2026, HC Technology was granted a utility model patent (No. CN224047052U) for an N-methylaniline wastewater treatment device whose dual-stage series adsorption structure enables online resin transfer and replacement, plus regeneration without shutdown.
Suzhou Hengchang Biotechnology Co., Ltd. has officially launched a comprehensive website renovation, covering page design, product information, factory photographs, and overall user experience improvements.
On March 22, 2026, the Party Secretary of Suzhou reviewed key technical upgrading projects in the Suzhou Economic Development Zone, making the company his first stop. He toured the central control room, observed production lines, and learned about financing and market sales, encouraging key technology breakthroughs, process optimization, and market expansion.
In October 2025, Suzhou Hengchang Biotechnology Co., Ltd. signed one of Suzhou's first overseas IP rights-protection insurance policies. The coverage helps cut the cost of defending its IP rights overseas and supports the company's international business.
Since late 2024, the company has received a total of 15 million CNY in working capital support in tranches coordinated by the Suzhou Economic Development Zone, funding operations during the advancement of its pharmaceutical excipient and 3,000-ton annual capacity N-methylaniline upgrading projects.
In December 2024, the company's 3,000-ton annual capacity N-methylaniline technical upgrading project passed the safety facility design review by the Suzhou Municipal Emergency Management Bureau, following its safety conditions review approval in August 2024. Both safety review procedures are complete, laying a compliance foundation for project implementation.
Search
Try a different keyword, or clear the search to browse all updates.
Search
Search by product name, CAS number, or news title.
Search assets are still loading. Please try again shortly.